February 8, 2008
Enbrel effective in pediatric psoriasis
Analysis of:
New Study Reports Enbrel (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents | www.wyeth.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: This study will expand the use of Enbrel in newer populations. this is important in that Humira just received approval for adults, and the market has become more competitive. This is good news for children with severe resistant psoriasis.
Analysis: This will have a positive impact on sales of Enbrel as this is the only biologic studied in the pediatric age group. the impetus is now on the other companies like Abbott and Centocor to do the same.
Analysis: This will have a positive impact on sales of Enbrel as this is the only biologic studied in the pediatric age group. the impetus is now on the other companies like Abbott and Centocor to do the same.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Is Celebrex Next ?
November 18, 2008
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
A closer look
November 11, 2008